TREATMENT STRATEGIES FOR SPINAL MUSCULAR ATROPHY

被引：4

作者：

Fuller, Heidi R. ^{[1
,2
]}

Barisic, Marija ^{[3
]}

Seso-Simic, Durdica ^{[4
]}

Speljko, Tea ^{[5
]}

Morris, Glenn E. ^{[1
,2
]}

Simic, Goran ^{[5
]}

机构：

[1] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England

[2] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England

[3] Univ Hosp Ctr Zagreb, Dept Ophthalmol, Zagreb, Croatia

[4] Zagreb E Med Ctr, Dept Paediat, Zagreb, Croatia

[5] Univ Zagreb, Sch Med, Dept Neurosci, Croatian Inst Brain Res, Zagreb 41001, Croatia

来源：

TRANSLATIONAL NEUROSCIENCE | 2010年 / 1卷 / 04期

关键词：

Clinical trials; Spinal muscular atrophy; SMN1; gene; SMN2; SMN protein; Treatment; Therapy; SURVIVAL MOTOR-NEURON; THYROTROPIN-RELEASING-HORMONE; SMN2; GENE-EXPRESSION; PLACEBO-CONTROLLED TRIAL; VALPROIC ACID INCREASES; SURROGATE END-POINTS; SEVERE MOUSE MODEL; STEM-CELLS; MESSENGER-RNA; IN-VITRO;

D O I：

10.2478/v10134-010-0045-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Progress in understanding the genetic basis and pathophysiology of spinal muscular atrophy (SMA), along with continuous efforts in finding a way to increase survival motor neuron (SMN) protein levels have resulted in several strategies that have been proposed as potential directions for efficient drug development. Here we provide an overview on the current status of the following approaches: 1) activation of SMN2 gene and increasing full length SMN2 transcript level, 2) modulating SMN2 splicing, 3) stabilizing SMN mRNA and SMN protein, 4) development of neurotrophic, neuroprotective and anabolic compounds and 5) stem cell and gene therapy. The new preclinical advances warrant a cautious optimism for emergence of an effective treatment in the very near future.

引用

页码：308 / 321

页数：14

共 157 条

[101] CLINICAL-PHARMACOLOGY OF SODIUM-BUTYRATE IN PATIENTS WITH ACUTE-LEUKEMIA [J].

MILLER, AA ;

KURSCHEL, E ;

OSIEKA, R ;

SCHMIDT, CG .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09) :1283-1287

[102] A placebo-controlled trial of gabapentin in spinal muscular atrophy [J].

Miller, RG ;

Moore, DH ;

Dronsky, V ;

Bradley, W ;

Barohn, R ;

Bryan, W ;

Prior, TW ;

Gelinas, DF ;

Iannaccone, S ;

Kissel, J ;

Leshner, R ;

Mendell, J ;

Mendoza, M ;

Russmann, B ;

Samaha, F ;

Smith, S .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 191 (1-2) :127-131

[103] A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2 [J].

Monani, UR ;

Lorson, CL ;

Parsons, DW ;

Prior, TW ;

Androphy, EJ ;

Burghes, AHM ;

McPherson, JD .

HUMAN MOLECULAR GENETICS, 1999, 8 (07) :1177-1183

[104] Cellular therapies in motor neuron diseases [J].

Nayak, Mamatha S. ;

Kim, Yun-Sook ;

Goldman, Michelle ;

Keirstead, Hans S. ;

Kerr, Douglas A. .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (11-12) :1128-1138

[105] PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons [J].

Ning, Ke ;

Drepper, Carsten ;

Valori, Chiara F. ;

Ahsan, Mansoor ;

Wyles, Matthew ;

Higginbottom, Adrian ;

Herrmann, Thomas ;

Shaw, Pamela ;

Azzouz, Mimoun ;

Sendtner, Michael .

HUMAN MOLECULAR GENETICS, 2010, 19 (16) :3159-3168

[106]

Oppenheim RW, 2001, J NEUROSCI, V21, P1283

[107] The changing natural history of spinal muscular atrophy type 1 [J].

Oskoui, M. ;

Levy, G. ;

Garland, C. J. ;

Gray, J. M. ;

O'Hagen, J. ;

De Vivo, D. C. ;

Kaufmann, P. .

NEUROLOGY, 2007, 69 (20) :1931-1936

[108] Spinal muscular atrophy [J].

Oskoui, Maryam ;

Kaufmann, Petra .

NEUROTHERAPEUTICS, 2008, 5 (04) :499-506

[109] Daily salbutamol in young patients with SMA type II [J].

Pane, Marika ;

Staccioll, Susanna ;

Messina, Sonia ;

D'Arnico, Adele ;

Pelliccioni, Marco ;

Mazzone, Elena S. ;

Cuttini, Marina ;

Alfieri, Paolo ;

Battinif, Roberta ;

Main, Marion ;

Muntoni, Francesco ;

Bertini, Enrico ;

Villanova, Marcello ;

Mercuri, Eugenio .

NEUROMUSCULAR DISORDERS, 2008, 18 (07) :536-540

[110] The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue [J].

Park, KI ;

Teng, YD ;

Snyder, EY .

NATURE BIOTECHNOLOGY, 2002, 20 (11) :1111-1117

← 6 7 8 9 10 11 12 13 14 15 →